Omega Healthcare director granted 6,205 deferred units

OMEGA HEALTHCARE INVESTORS INC director Anand Kapila K received an equity award in the form of deferred stock units.

Rhea-AI Filing Summary

OMEGA HEALTHCARE INVESTORS INC director Anand Kapila K received an equity award in the form of deferred stock units. On the reported date, he was granted 6,205 Deferred Stock Units at no cash cost as an annual restricted stock grant elected to be taken in this form.

Each unit converts into one share of common stock, and related dividends can also be credited as additional units if elected. The units are restricted from transfer or sale until Omega's 2027 Annual Meeting of Shareholders, defined as the vesting date, and will convert into common shares upon separation from service, death, disability, or other specified plan events. Following this grant, he holds 44,992 Deferred Stock Units directly.

Insider Trade Summary

Grant/Award: 6,205 shares

Grant/Award 1 txn

Insider Anand Kapila K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	6,205	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 44,992 contracts (Direct)

Footnotes (4)

1. F1. Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.
2. F2. These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date").
3. F3. These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.
4. F4. These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

Key Figures

Deferred stock units granted: 6,205 units Total deferred units after grant: 44,992 units Grant price per unit: $0.0000 per unit +1 more

4 metrics

Deferred stock units granted 6,205 units Annual restricted stock grant taken as Deferred Stock Units

Total deferred units after grant 44,992 units Holdings following the reported transaction

Grant price per unit $0.0000 per unit No cash cost equity award to director

Conversion ratio 1 unit : 1 share Each Deferred Stock Unit converts into one common share

Key Terms

Deferred Stock Units, Vesting Date, separation from service

3 terms

Deferred Stock Units financial

"These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Vesting Date financial

"The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date")."

separation from service financial

"The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OHI director Anand Kapila K report on this Form 4?

Director Anand Kapila K reported receiving 6,205 Deferred Stock Units as an equity award. These units were granted at no cash cost as his annual restricted stock grant, elected in deferred form rather than standard restricted stock, increasing his deferred holdings in Omega Healthcare Investors.

How many deferred stock units does OHI director Anand Kapila K hold after this grant?

After the 6,205-unit grant, Anand Kapila K holds 44,992 Deferred Stock Units directly. This figure reflects his accumulated deferred equity awards in Omega Healthcare Investors and shows the size of his deferred stake tied to the company’s common stock performance over time.

How do OHI deferred stock units convert into common shares for Anand Kapila K?

Each Deferred Stock Unit converts into one share of Omega Healthcare Investors common stock. The plan provides that conversion occurs upon separation from service, death, disability, or certain other specified events, giving the director future delivery of shares instead of immediate stock ownership today.

When do Anand Kapila K’s new OHI deferred stock units vest and become transferable?

The new units are restricted from sale or transfer until Omega Healthcare Investors’ 2027 Annual Meeting of Shareholders, defined as the Vesting Date. Until then, they remain subject to transfer restrictions even though they are credited as deferred stock units linked to common shares.

Can dividends on OHI shares increase Anand Kapila K’s deferred stock unit balance?

Yes. If elected under the plan, dividends on Omega Healthcare Investors common stock are converted into additional Deferred Stock Units. This means future dividends can incrementally increase the director’s deferred unit balance, further tying his compensation to ongoing shareholder dividend payments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anand Kapila K

(Last) (First) (Middle)

303 INTERNATIONAL CIRCLE

SUITE 200

(Street)

HUNT VALLEY MARYLAND 21030

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)(2)	06/05/2026		A		6,205		(3)	(4)	Common Stock	6,205	$0	44,992	D

Explanation of Responses:

1. Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.

2. These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date").

3. These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.

4. These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.

	/s/ Meghan C. Lyons, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)